Regeneron Pharmaceuticals
REGN
#232
Rank
A$124.16 B
Marketcap
$1,130
Share price
-0.87%
Change (1 day)
-6.85%
Change (1 year)

EPS for Regeneron Pharmaceuticals (REGN)

EPS in 2023 (TTM): $56.24

According to Regeneron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $57.20. In 2022 the company made an earnings per share (EPS) of $62.04 a decrease over its 2021 EPS that were of $117.05.

EPS history for Regeneron Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$56.24-9.35%
2022$62.04-47%
2021$117.05133.36%
2020$50.1669.13%
2019$29.66-14.44%
2018$34.66100.71%
2017$17.2731.78%
2016$13.1138.96%
2015$9.4372.55%
2014$5.47-17.55%
2013$6.63-44.98%
2012$12.05-422.54%
2011-$3.7492.13%
2010-$1.9449.41%
2009-$1.30-15.84%
2008-$1.55-36.88%
2007-$2.45-9.6%
2006-$2.714.12%
2005-$2.60-323.68%
2004$1.16-135.51%
2003-$3.28-24.38%
2002-$4.3356.35%
2001-$2.77187.3%
2000-$0.96-16%
1999-$1.15177.78%
1998-$0.41-35.71%
1997-$0.64-68.42%
1996-$2.04

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$21.66-62.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-$6.29-111.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$28.26-50.59%๐Ÿ‡บ๐Ÿ‡ธ USA
$21.56-62.30%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.73-89.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$4.87-91.49%๐Ÿ‡ซ๐Ÿ‡ท France